Skip to main content

Comparison of the effect of autoclaved and non-autoclaved live soil exposure on the mouse immune system

Effect of soil exposure on immune system



. Lack of exposure to the natural microbial diversity of the environment has been linked to dysregulation of the immune system and numerous noncommunicable diseases, such as allergies and autoimmune disorders. Our previous studies suggest that contact with soil material, rich in naturally occurring microbes, could have a beneficial immunoregulatory impact on the immune system in mice and humans. However, differences in the immunomodulatory properties of autoclaved, sterile soil material and non-autoclaved, live soil material have not been compared earlier.


. In this study, we exposed C57BL/6 mice to autoclaved and live soil powders that had the same rich microbiota before autoclaving. We studied the effect of the soil powders on the mouse immune system by analyzing different immune cell populations, gene expression in the gut, mesenteric lymph nodes and lung, and serum cytokines. Both autoclaved and live soil exposure were associated with changes in the immune system. The exposure to autoclaved soil resulted in higher levels of Rorγt, Inos and Foxp3 expression in the colon. The exposure to live soil was associated with elevated IFN-γ concentration in the serum. In the mesenteric lymph node, exposure to live soil reduced Gata3 and Foxp3 expression, increased the percentage of CD8 + T cells and the expression of activation marker CD80 in XCR1+SIRPα migratory conventional dendritic cell 1 subset.


. Our results indicate that exposure to the live and autoclaved soil powders is not toxic for mice. Exposure to live soil powder slightly skews the immune system towards type 1 direction which might be beneficial for inhibiting type 2-related inflammation. Further studies are warranted to quantify the impact of this exposure in experimental type 2 inflammation.

Peer Review reports


The biodiversity hypothesis suggests that decreased interaction with microbes can lead to an imbalance in the human microbiota (referred to as dysbiosis), which in turn will contribute to the development of immune-mediated diseases including asthma, allergies, type 1 diabetes, inflammatory bowel disease, rheumatoid arthritis, and even neurological disorders such as Alzheimer and Parkinson’s disease as well as metainflammation associated hypertension, cardiovascular diseases and type 2 diabetes [1,2,3,4,5,6,7,8]. Increasing evidence has linked the high hygiene standards of modern lifestyle and the loss of biodiversity in urbanized living environments to a decrease in the richness of indoor microbiota [9, 10] and commensal microbiota in the human skin and gut [11,12,13,14,15]. It is known that exposure to nature-derived microorganisms in early life is associated with the modulation of the immune system: Contact with agricultural land, living on farms, green space around home and housing a pet have been associated with the below-average risk of immune dysfunction [16,17,18,19,20,21,22]. Furthermore, it has been shown that people who suffer from immune-mediated diseases have lower diversity of commensal bacteria [5, 23,24,25].

To counterbalance this effect, different interventions have been tested to improve microbial diversity and reduce the risk of inflammatory disorders. Typically, studies have focused on probiotics, prebiotics, postbiotics and fecal transplants, and while, for instance, in the treatment of Clostridium difficile infection fecal transplantation treatment has proven successful [26], often attempts to address dysbiosis and immune disorders have shown mixed results [27,28,29,30,31,32]. Most methods rely on one or a few strains of bacteria while little attention has been given to exposure to natural microbial biodiversity as an immunomodulatory and therapeutic method [33].

We have previously utilized a novel approach of bringing humans and mice into contact with microbially rich plant- and soil-based material. In humans, exposure to this material increased commensal microbial diversity, which was linked to higher levels of anti-inflammatory cytokines TGF-β and IL-10 in plasma, and increased IL-10/IL-17 ratio and proportion of regulatory T cells [34,35,36,37]. The shift in the microbiota persisted for the duration of a 2-year study [38]. In mice, autoclaved forest-derived soil powder reduced the level of IL-21 and IL-17 F in serums as well as decreased the release of pro-inflammatory signals, such as IL-1β, IL-5, IL-6, IL-13 and TNF, in activated splenocytes [39]. Similar results, demonstrating an immunoregulatory effect, were also reported in a mouse soil exposure study by Ottman et al. [40].

Here, we compared the effects of autoclaved and non-autoclaved, live soil powder on the mouse immune system, to understand if soil-derived material conveys immunoregulatory signals, and to test whether the exposure to the materials is toxic for mice. To this end, we analyzed different lymphoid and myeloid subsets in the mouse spleen and gut-draining mesenteric lymph nodes (mLN) by flow cytometry and studied the expression of important immune-related genes in different organs by qPCR. We also determined the concentration of different inflammatory and anti-inflammatory cytokines in the mouse serum. To our knowledge, this is the first study to analyze how sterile and live soil materials compare as immunomodulatory tools.


Cytokine profile in Serums

Exposure to soil powder has been linked to changes in serum cytokine concentrations both in humans and mice [34, 35, 37, 39]. We compared the effect of the autoclaved soil powder with the live soil powder preparate in wild type C57BL/6 mice along with a control group that was maintained in clean bedding. Mice in two groups were subjected to the treatments for 1 h, 5 days a week, for three weeks, while the third i.e.control group was not in soil contact. We found an increased INF-γ in serums from animals exposed to the non-autoclaved live powder compared to the control group (p = 0.0256, Fig. 1) but the autoclaved material did not induce IFN-g. Other significant differences in serum cytokines were not observed. The measured cytokines included IL-10, IL-12p70, IL-13, IL-6, IL-25, IL-1β, IL-2, IL-4, IL-5, TNF and IL-33 (Fig. 1). Additionally, IL-17 F, IL-21 and IL-31 were measured but their levels were not detectable.

Fig. 1
figure 1

Exposure to live soil increases serum IFN-γ concentration. Sera from exposed animals were collected at day 21 and analyzed for cytokine concentrations using U-Plex from Meso Scale Discovery. Serum concentrations (pg/mL) are shown. Data are shown as scatter plots with mean and 95% CI (n = 8 per group, from two independent exposure experiments). Each symbol represents an individual mouse, lines indicate the mean. The data was analyzed with One-way ANOVA with Tukey´s multiple comparison test, *p < 0.05

Myeloid immune profile in mLN and spleen

To characterize the immune status and identify possible immunomodulation induced by the treatments, we next characterized the myeloid compartment in gut-draining mLNs and spleen by flow cytometry. The analyzed cell types included dendritic cells, macrophages, monocytes, granulocytes and their subsets. Detailed different cell types, subsets and defining markers are presented in Supplementary Table 1. Gating strategy is shown in Supplementary Fig. 2. In mLN, we found that while there were no differences in the proportion of cDC1 and cDC2 (type 1 and type 2 conventional dendritic cells, respectively) the co-stimulatory molecule and activation marker CD80 was elevated in migratory cDC1 in the group that was exposed to live soil, when compared to control or autoclaved soil groups (p = 0.359 and p = 0.0177, respectively) (Fig. 2A-B). Migratory cDC1 dendritic cells are defined as CD11cIntMHCIIHighXCR1+SIRPα, whereas migratory cDC2 cells are CD11cHighMHCIIHighXCR1SIRPα+. In spleen, no significant differences were found and overall, differences in cell subsets between treatments were minor. Third parameter Uniform manifold Approximation and projection for Dimension reduction (UMAP) plots are shown in Supplementary Fig. 1 for the myeloid cells (represented by mLN cells), demonstrating nearly identical subset composition.

Fig. 2
figure 2

Migratory conventional dendritic cells in mesenteric lymph nodes express an activated phenotype upon live soil exposure. Spleen and mesenteric lymph nodes were collected at day 21 and myeloid cell compartments were analyzed using flow cytometry. Conventional dendritic cells 1 (cDC1) and 2 (cDC2) were defined as XCR1+SIRPα or XCR1SIRPα+, respectively, and quantified from the from the CD11cInt/HiMHCIIHi population (A). The percentage of cDC1 and cDC2 showed no differences between mouse groups. (B) CD80 expression on cDC1 and cDC2 was quantified using median fluorescence intensity as a measure for activation. Data are shown as scatter plots with mean and 95% CI (n = 8 per group, from two independent exposure experiments). Each symbol represents an individual mouse, lines indicate the mean. The data was analyzed with One-way ANOVA with Tukey´s multiple comparison test, *p < 0.05

Lymphoid immune profile in mLN and spleen

We next analyzed the effect of soil exposure to the lymphoid compartment by flow cytometry. Cells were stained for markers separating T cells and B cells and their subsets. Detailed subsets and markers are depicted in Supplementary Tables 2 and gating strategy is shown in Supplementary Fig. 3. In mLN, we saw an increase of cytotoxic CD8+ of total CD3+ cells, (Fig. 3A). The difference was seen when control group was compared to the live soil group (p = 0.0417). Additionally, the cytotoxic effector memory population (CD8+CD44+CD62L) in autoclaved soil group seemed to have a trend of decreased expression of the early activation marker CD69, but this was not statistically significant (p = 0.46; Fig. 3B). In spleen there were no differences in the proportion of CD3+, CD3+CD4+, CD3+CD8+ nor B1 or B2 cells (defined as CD3CD19+ B220 and CD3CD19+B220+, respectively) (Fig. 3C-E), but IgM expression in B1 cells decreased after exposure to autoclaved soil compared to the control group (p = 0.0319) (Fig. 3D). As with the myeloid compartment, lymphoid cell composition was rather similar in mLN and spleen regardless of the treatment, as exemplified by third parameter UMAPs of splenic cells in Supplementary Fig. 1.

Fig. 3
figure 3

Exposure to autoclaved soil downregulates IgM in B1 cells from spleen while live soil upregulates CD8+T cells in mesenteric lymph nodes. Spleen and mesenteric lymph nodes were collected at day 21 and lymphoid cell compartments were analyzed using flow cytometry. (A) T cells (CD3+), helper T cells (CD3+ CD4+), cytotoxic T cells (CD3+ CD8+) and B cells (CD19+) in the mLN. (B) The percentage of CD69 + effector cytotoxic T cells (CD8+ CD44+ CD62L) in the mLN. (C) CD3+, CD4+, CD8+ and CD19+ cells in spleen. (D) B1 cells (CD19+ B220) and IgM expression on B1 cells in spleen. MFI was measured from total B1 population. (E) B2 cells (CD19+ B220+) and IgM expression on B2 cells in spleen. MFI was measured from total B2 population. Data are shown as scatter plots with mean and 95% CI (n = 8 per group, from two independent exposure experiments). Each symbol represents an individual mouse, lines indicate the mean. The data was analyzed with One-way ANOVA with Tukey´s multiple comparison test, *p < 0.05

Splenocyte activation response

We previously observed that splenocytes from animals exposed to autoclaved soil powder expressed less pro-inflammatory cytokines when stimulated by PMA and ionomycin in vitro [39]. We now stimulated splenocytes from the different treatment groups with a more physiologically relevant anti-CD3/anti-CD28 antibody activation. T cell response was measured by flow cytometry using CD69, CD25, PD-1 and CTLA-4 expression. We found no significant differences in the percentage of activation nor in the magnitude of these markers mean fluorescence intensity at 24 h post-stimulation (Fig. 4A-B, CD69 only shown) when compared to control group. Moreover, we analyzed the profile of cytokine secretion (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IFN-γ, TNF) on the supernatants at different time points (Fig. 4C). No significant differences were found in the different cytokines at 48- or 72-hours post-stimulation. IL-17 F, IL-21, IL-25, IL-31 and IL-33 were not detected.

Fig. 4
figure 4

T Cytokine secretion is not affected by exposure to autoclaved or live soil in an anti-CD3/anti-CD28 activation assay. On day 21, single-cell suspension from splenocytes was prepared, cells were rested overnight and then either left unstimulated or stimulated with anti-CD3/anti-CD28 antibody cocktail. CD69 expression was assessed at 24 h post stimulation using flow cytometry for (A) CD4+ T cells and (B) CD8+ T cells. (C) Supernatants from unstimulated or stimulated splenocytes were collected at 48 and 72 h and analyzed using U-Plex from Meso Scale Discovery. Each symbol represents an individual mouse, lines indicate the mean 95% C.I. (n = 4 for Unstimulated and 48 h treatment, and n = 8 for 72 h, from two independent exposure experiments). The data was analyzed with One-way ANOVA

Gene expression analysis of lung, small intestine, colon and mLN

We then analyzed a set of genes important for the immune response in organs that could come in direct or indirect contact with the soil material or antigens from it, namely the colon, mesenteric lymph nodes, lung, and small intestine (Fig. 5). In the colon, Inos was significantly upregulated in autoclaved soil treated animals compared to the control and the live soil group (p = 0.0044 and 0.0046, respectively, Fig. 5A). Quite interestingly, Rorγt was upregulated in the autoclaved soil group when compared to the control and live soil group (p = 0.0347 and 0.0009, respectively). Autoclaved soil treated animals also showed higher levels of Foxp3 expression compared to the control group (p = 0.0333), but it was not differently expressed in the live soil treated animals (Fig. 5A). In contrast to colon results, in the mLN, Foxp3 and Gata3 were significantly downregulated (p = 0.0039 and 0.0339, respectively) in the live soil treated animals compared to the control group, but no difference was found in the autoclaved soil-treated animals (Fig. 5B).

Fig. 5
figure 5

In colon, exposure to autoclaved soil upregulatesinos, RorγtandFoxp3expression while live soil exposure downregulatesRorγt. In mesenteric lymph nodes, live soil exposure downregulatesGata3andFoxp3expression. Gene expression changes in different organs after no treatment, autoclaved or live soil exposure. RNA was extracted from the colon, mLN, lung or small intestine. Gene expression was measured using qPCR. (A) Macrophage activation associated genes (Arg1 and inos) and T cell lineage associated genes (Tbet, Gata3, Rorγt, and Foxp3), in the colon. (B) T cell lineage-associated genes (Tbet, Gata3, Rorγt, and Foxp3) were measured in the mLN. (C) Macrophage activation associated genes (Arg1 and inos), Il21 cytokine and Foxp3 expression were measured in the lung. (D) Macrophage activation associated genes (Arg1 and inos) and T cell lineage associated genes (Tbet, Gata3, Rorγt, and Foxp3), in the small intestine. Values are shown as scatter plots with bar as mean and SEM (n = 8 per group, from two independent exposure experiments). Fold changes were calculated using control group mean and all data points were compared accordingly, including the control group. The data were analyzed with One-way ANOVA test with Tukey´s multiple comparison test, *p < 0.05, **p < 0.01

In the respiratory tract, no major differences were found in macrophage polarization genes Arg1 and Inos, while the previously reported downregulation of Il-21 was slightly reduced in autoclaved soil animals, but the difference was not statistically significant. (Fig. 5C). Finally, we measured the same macrophage associated genes in the small intestine without significant differences (Fig. 5D). T-cell polarization related transcription factors Tbet, Gata3, Rorγt and Foxp3 did not indicate any significant changes (Fig. 5D).


The biodiversity hypothesis of immune-mediated diseases proposes that early life exposure to microbial diversity protects against immune-mediated diseases. To test this, immunomodulatory interventions to recapitulate natural microbial diversity in laboratory conditions without confounding factors are needed. In contrast to many previous studies and therapeutic interventions, which have focused on recapitulating existing microbiome and interventions using a single or a few microbial strains [27,28,29,30,31,32], our group has shown potentially beneficial immunological effects in human microbiota interventions using highly diverse intervention materials [34,35,36,37,38]. To dissect the molecular mechanisms behind these observed findings, animal models and the comprehensive immunological studies of different immunologically active organs and cells are needed. Even though Ottman et al. [40] did a single study using commercially manufactured soil enriched with a Bacillus strain, and we previously showed that autoclaved soil powder induced certain anti-inflammatory features in mice cultured in sterile conditions [39], the precise comparison of the effects of exposure to sterile versus live soil has been missing. In the current study, we compared the effects of autoclaved vs. non-autoclaved live soil powder on the immune system of WT B6 mice that were housed in non-sterile conditions. The current study can be considered as the first attempt to fill this crucial gap in knowledge.

Several details in our results support the hypothesis that both live and autoclaved soil trigger immune response. The notion that serum IFN-g level is elevated by live soil is logical. It suggests that microbial components in soil trigger intracellular type1 immune response. This is supported also by the fact that IL-12p70 levels are elevated in several mice from live soils or autoclaved soil groups, but in the control group none of the mice showed elevation of IL-12p70 expression (Fig. 1). On the other hand, the unchanged expression of most pro-inflammatory cytokines would support the non-toxic nature of both autoclaved and live soil preparates for mice. Interestingly, while alarmin IL-33 expression was not statistically different between the treatment groups, it is noteworthy that in all control group mice the expression of IL-33 was low, while there were several mice in autoclaved and live soil groups showing elevated expression of this alarmin. This further supports the hypothesis that both live and autoclaved soil has the potential to trigger immune response, in contrast to soil-free cages. Similar findings have been done using live or inactivated probiotics demonstrating that both formulas can be immunologically active and function as immunobiotics and postbiotics [41, 42].

Differences of the cellular landscape between control group and autoclaved or live soil exposed groups were subtle. Dendritic cells are critical sensors of antigen diversity by providing structural data of the antigens to CD4 T cells. In mice, myeloid DCs are classically divided to plasmacytoid DCs, and type 1 and type 2 DCs [43]. Of these, we found that activation marker CD80 was significantly elevated in migratory, non-autoclaved live soil-treated cDC1 cells. Functionally these cells regulate antigen cross-presentation, while cDC2s participate more in CD4 T cells differentiation [44]. This would be logical as these cells were likely activated by encountering the live soil-derived microbes. However, the fact that monocytes were not activated is somewhat confusing, suggesting that mammalian response to soil exposure is more complex than could be imagined based on the functions of individual antigens. In the lymphoid compartment, slight increase in the proportion of CD8+ T cells in the gut draining mLN from the live soil group was observed and could be related to the higher activation state of cDC1 cells. The notion that IgM levels were lower in B1 B cells from the spleen of autoclaved soil exposed mice is interesting. It might indicate B1 B cell activation and further differentiation to plasma cells. Natural IgM from B1 cells has been suggested to be important for homeostasis and immunity [45, 46], but also in certain cases promote inflammation by activating complement (discussed in [47]). Whether this might provide beneficial anti-inflammatory consequences, for example in experimental autoimmune models, remains to be studied.

Our results in colon and mLN indicate that exposure to live soil decreases Gata3 and Foxp3 expression in the mLN while autoclaved soil increased Foxp3 expression in the colon. This is in contrast to small intestine, where no immunological effects were seen. Gata3 and Foxp3 downregulation in the mLN are in line with the type 1 response elicited by the live soil material [48], while the autoclaved, inactivated soil was not able to produce a similar effect. This is also supported by the elevated Tbet expression in several live soil treated animals. However, the increased Foxp3 and Rorγt expression in the colon upon exposure to autoclaved material could indicate a local immunomodulatory and homeostatic effects in the absence of a stronger inflammatory reaction [49,50,51]. One possibility is that the antigen diversity provided in the soil also modulates the complex lymphocyte trafficking between tissues and secondary lymphoid organs in the gut [52]. The difference between small intestine and colon could also reflect the possible lower microbial flexibility of the upper intestine. Obviously, the current study was not designed to survey these dilemmas, but based on our findings it seems crucial to consider appropriate sampling procedures in future mammalian, including human, trials focusing on gut function and microbiota. Our previous work indicated relatively subtle changes in the gut microbiota, when mice were exposed to autoclaved soil in sterile environment [39]. For this, in this work we focused to host response to the treatment, rather than the microbiome composition. Future experiments will be needed to carefully assess the microbiome upon soil challenge. It is also quite interesting that a single bacterial species such as Akkermansia muciniphila in the gut may provide a protective tolerance against autoimmune reactions in mice [53].

One limitation of this study is the fact that we were unable to perform these experiments in similar sterile conditions as our previous work [39] due to risk of contaminating the Institutional Animal Facility using the non-autoclaved live material. For this, the exposure of the animals was done in less sterile conditions which may explain part of the differences between the current and our previous study. The exposure of the animals to environmental microbes in less sterile conditions might reduce differences between groups, as the animals would have a more mature and primed T cell phenotype at the onset of the experiment, instead of the naïve phenotype typical for animals housed in laboratory conditions [54]. Additionally, since the decrease in lung IL-21 mRNA expression with autoclaved soil was not statistically significant in mice housed in less sterile conditions (Fig. 5C), while the difference was found between exposed and control mice in sterile conditions in our earlier study [39], we speculate that airborne spores may play a role in the immune response of our mice model. Another limitation is that only female mice were used as we wanted to exclude the effect of gender in the analysis due to relatively small group sizes (n = 8).

Performing the experiment in less sterile environment reflects a more realistic situation. While still limited to an inbred mouse line, the less sterile environment allows us to realistically evaluate the efficacy of microbially rich and autoclaved soil on immunomodulation. It is also possible that the relatively small size of individual groups may have influenced the statistical power to detect modest changes between the groups. Future experiments elucidating the capability of this immunomodulation to counterbalance, for example, experimental allergic inflammation in mice, are well-warranted.


In conclusion, live soil treatment seems to have immunological effects. It induced IFN-γ in serum, cDC1 activation and reduced Gata3 expression in mLN. Some of the immunological outcomes differed between the tissues studied and the treatments the mice were exposed to. For example, Foxp3 expression was elevated in the colons of mice exposed to autoclaved soil while it was reduced in mLNs from live soil-exposed animals. The reasons for these differences are not known, but they may reflect the distinct immunological functionalities of different sites, or alternatively, changes in microbial antigen content during autoclavation. The current study opens possibilities to tailor the effects of biodiversity-based immunomodulation by modulating the content and quality of the intervention material.


Animals and exposure to plant and soil-based extract. The plant and soil-based powder used for the exposure was manufactured by the Laboratory of Environmental Ecology, University of Helsinki, as described previously [11, 34, 55]. It comprised of a mixture of sieved composted materials including six commercial gardening soils (trade names: Musta Multa, Niittymulta, Nurmikkomulta, Perennamulta, Puistomulta and Viljelymulta), deciduous leaf litter, peat and agricultural sludge, and dried and crushed Sphagnum moss.

A total of 24 female C57BL/6JRj mice from Janvier Labs (Le Genest-Saint-Isle, France) were used in this study. The mice were 7–8 weeks of age at the beginning of the exposure period. Animals were housed in groups of 4 animals in open ventilated cages with aspen bedding and cardboard cage enrichment and nests (Scanbur, Karlslunde, Denmark) at Natural Resources Institute Finland (Luke), Jokioinen. The animals were exposed daily to soil material (inactivated by autoclaving or live, non-autoclaved soil) for one hour, five days a week for three weeks (21 days). For the exposure, the mice were transferred to a new clean cage (floor 360 cm2) with 300 mL of clean aspen bedding and 50 mL of lyophilized soil material sprinkled on top. Control animals were placed in a new cage with clean bedding only, for one hour. The lyophilized soil samples were dusty and visibly adhered to mice during the exposure. The animals from different groups (autoclaved soil, live soil or control) were fed with the same food (SAFE D113, Safe, Rosenberg, Germany) and autoclaved drinking water ad libitum, but were kept in different rooms and the researchers handling the mice changed single use protection clothes every time before handling animals of different groups to avoid cross contamination. During the exposure, the cage with mice was kept in a hood to avoid contamination by soil dust and afterwards the hood was cleaned with 70% ethanol. At day 21 mice were euthanized in a CO2 chamber and organs were subsequently collected for analysis. The experiment was performed twice, with 4 animals per group (autoclaved soil, live soil or control) both times.

Flow cytometry. Single cell suspensions of spleen and mLN were prepared by mechanic dissociation of the organs with a 10 mL syringe plunger and 40 μm cell strainer (Thermo Fisher Scientific, Waltham, MA, US) in PBS−/− buffer (pH 7.2, Thermo Fisher Scientific) supplemented with 2% FBS and 2 mM EDTA. The red blood cells of the spleen samples were lysed with 1 min ACK (Lonza, Basel, Switzerland) treatment. Single cell suspensions were treated with Rat Anti-Mouse CD16/CD32 antibodies (Mouse BD Fc Block™, Becton Dickinson Biosciences, Franklin Lakes, NJ) for 5 min at 4 °C before staining. The cells from spleens and lymph nodes were divided into two panels with an emphasis on either myeloid cells (B220, CD3, CD11b, CD11c, CD64, CD80, CD103, CD169, F4/80, ICAM-1(CD54), Ly6C, MHCII, SIRPα (CD172), XCR1, modified from [56]) or lymphoid cells (B220, CD3, CD4, CD8, CD19, CD25, CD62L, CD44, CD69, CD127, IgM, Ly6G). Some splenocytes were activated (see below) before staining for B220, CD3, CD4, CD8, CD25, CD49b, CD69, CTLA-4, MHCII and PD-1 (CD279). Dead cells were stained with Fixable Viability Stain 780 (BD) for 15 min in PBS, RT. Antibody clone and manufacturer details are listed in Supplementary Table 3. After washing with 2% FBS, 1 mM EDTA, 0,05% NaN3 in PBS, cells were incubated with the antibody cocktail in BD Horizon Buffer for 20 min at 4 °C and then washed twice. Samples of the myeloid and lymphoid panel were fixed with 2% paraformaldehyde in PBS for 10 min, RT, washed twice and kept in washing buffer until analysis. Activated splenocytes were analyzed freshly after staining. All samples were run with BD FACSAria Fusion and subsequent data analysis was performed with FlowJo software (BD).

RNA extraction and RT-qPCR analysis. Spleen, mesenteric lymph node, lung, small intestine and colon samples were collected at day 21 and stored in RNALater (Thermo Fisher Scientific) after collection and stored at -80 °C until further use. Before RNA extraction, organs were homogenized using ceramic beads (VWR. Precellys®, CKMIX) with PowerLyzer® 24 homogenizer (Bertin Instruments, Bertin Technologies SAS, France) at 3200 rpm, 45 s, 3 times. The RNA was extracted using E.Z.N.A.® Total RNA Kit I (Omega Bio-tek, Inc.). Synthesis of cDNA from RNA samples was performed using iScript™ cDNA Synthesis Kit (Biorad, Hercules, CA, US). Gene expression was assessed using RT-qPCR. The qPCR reaction was prepared using SYBR Green Luna® Universal qPCR Master Mix (New England Biolabs Inc. Ipswich, MA, US) and samples were analyzed with ABI ABI QuantStudio 12 K Flex System (Thermo Fisher Scientific). In brief, three technical replicates were performed for each biological sample. Then, delta Ct values (dCt) were calculated using the difference between the target genes Ct averages to the 18s-rRNA Ct average value for each sample respectively. Later, ddCt values were obtained subtracting the dCt value for each sample to the dCt average value of the control group (including each sample from the control group compared to the control group mean). Finally, fold changes were calculated using the following formula: 2^-ddCt.

T cell activation assay. Spleens from animals were collected after euthanasia and single cell suspension was obtained as described above, after which the cells were rested overnight in RPMI 1640 with 10% FBS (Thermo Fisher Scientific), 1% L-glutamine (Lonza), and 1% penicillin/streptomycin (Lonza). The next day, splenocytes were stimulated on plates pre-coated with anti-CD3 (0,5 ug/mL) and anti-CD28 (1 ug/mL). Control cells were left untreated. Supernatants were collected at 48- and 72-hours post-stimulation and stored at -80 °C for cytokine measurement. A part of the cells was harvested for flow cytometry at 24 h time point.

Serum and supernatant cytokine analysis. Mouse sera were collected by cardiac puncture after euthanasia and stored at -80 °C until further use. Supernatants were collected from activated splenocytes as described above. Cytokine quantification for IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-17E/IL-25, IL17F, IL-21, IL-31, IL-33 and TNF was performed using a custom version of U-PLEX Biomarker Group 1 (ms) Assay and analyzed with MESO Quickplex SQ 120 according to manufacturer’s instructions (kit and instrument by Meso Scale Discovery, Rockville, MD, US).

Statistical analysis. Normal distribution was assessed for each individual data set using Anderson-Darling test (alpha = 0.05). Non-parametric data were analyzed using a Kruskal-Wallis (alpha = 0.05, two tailed), parametric data were analyzed using a One-way ANOVA, as appropriate (alpha = 0.05, two tailed). All immunological data sets were analyzed using GraphPad Prism 8.0 (GraphPad Inc., USA).

Data Availability

All data and materials are available for qualified researchers upon request. Contact person for access to the raw data: Ilkka Junttila,





lymph node


mesenteric lymph node


regulatory T cell


Transforming growth factor beta


Cluster of differentiation


dendritic cell


Granulocyte-macrophage colony-stimulating factor


Tumor necrosis factor


Uniform manifold Approximation and projection for Dimension reduction


  1. Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19(2):179–94.

    Article  CAS  PubMed  Google Scholar 

  2. Dinan TG, Cryan JF. The Microbiome-Gut-Brain Axis in Health and Disease. Gastroenterol Clin North Am. 2017;46(1):77–89.

    Article  PubMed  Google Scholar 

  3. Haahtela T. A biodiversity hypothesis. Allergy. 2019;74(8):1445–56.

    PubMed  Google Scholar 

  4. Haahtela T, Alenius H, Lehtimäki J, Sinkkonen A, Fyhrquist N, Hyöty H, et al. Immunological resilience and biodiversity for prevention of allergic diseases and asthma. Allergy. 2021;76(12):3613–26.

    Article  CAS  PubMed  Google Scholar 

  5. Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A. 2012;109(21):8334–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kondrashova A, Seiskari T, Ilonen J, Knip M, Hyöty H. The Hygiene hypothesis and the sharp gradient in the incidence of autoimmune and allergic diseases between russian Karelia and Finland. APMIS. 2013;121(6):478–93.

    Article  PubMed  Google Scholar 

  7. Noce A, Marrone G, Di Daniele F, Ottaviani E, Wilson Jones G, Bernini R, et al. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases. Nutrients. 2019;11(5):1073.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Rooney CM, Mankia K, Emery P. The role of the Microbiome in driving RA-Related autoimmunity. Front Cell Dev Biol. 2020;8:538130.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hui N, Parajuli A, Puhakka R, Grönroos M, Roslund MI, Vari HK, et al. Temporal variation in indoor transfer of dirt-associated environmental bacteria in agricultural and urban areas. Environ Int. 2019;132:105069.

    Article  PubMed  Google Scholar 

  10. Parajuli A, Grönroos M, Siter N, Puhakka R, Vari HK, Roslund MI, et al. Urbanization reduces transfer of Diverse Environmental Microbiota Indoors. Front Microbiol. 2018;9:84.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hui N, Grönroos M, Roslund MI, Parajuli A, Vari HK, Soininen L, et al. Diverse Environmental Microbiota as a Tool to augment Biodiversity in Urban Landscaping materials. Front Microbiol. 2019;10:536.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lehtimäki J, Karkman A, Laatikainen T, Paalanen L, von Hertzen L, Haahtela T, et al. Patterns in the skin microbiota differ in children and teenagers between rural and urban environments. Sci Rep. 2017;7:45651.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Parajuli A, Hui N, Puhakka R, Oikarinen S, Grönroos M, Selonen VAO, et al. Yard vegetation is associated with gut microbiota composition. Sci Total Environ. 2020;713:136707.

    Article  CAS  PubMed  Google Scholar 

  15. Rook GA. Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc Natl Acad Sci U S A. 2013;110(46):18360–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Brugman S, Perdijk O, van Neerven RJJ, Savelkoul HFJ. Mucosal Immune Development in Early Life: setting the stage. Arch Immunol Ther Exp (Warsz). 2015;63(4):251–68.

    Article  CAS  PubMed  Google Scholar 

  17. Kim H, Sitarik AR, Woodcroft K, Johnson CC, Zoratti E. Birth Mode, Breastfeeding, Pet exposure, and antibiotic use: Associations with the gut microbiome and sensitization in children. Curr Allergy Asthma Rep. 2019;19(4):22.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Koskela HO, Happonen KK, Remes ST, Pekkanen J. Effect of farming environment on sensitisation to allergens continues after childhood. Occup Environ Med. 2005;62(9):607–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Lehtimäki J, Thorsen J, Rasmussen MA, Hjelmsø M, Shah S, Mortensen MS, et al. Urbanized microbiota in infants, immune constitution, and later risk of atopic diseases. J Allergy Clin Immunol. 2021;148(1):234–43.

    Article  PubMed  Google Scholar 

  20. Nurminen N, Cerrone D, Lehtonen J, Parajuli A, Roslund M, Lönnrot M, et al. Land Cover of Early-Life Environment modulates the risk of type 1 diabetes. Diabetes Care. 2021;44(7):1506–14.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Okada H, Kuhn C, Feillet H, Bach JF. The hygiene hypothesis for autoimmune and allergic diseases: an update. Clin Exp Immunol. 2010;160(1):1–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Ruokolainen L, von Hertzen L, Fyhrquist N, Laatikainen T, Lehtomäki J, Auvinen P, et al. Green areas around homes reduce atopic sensitization in children. Allergy. 2015;70(2):195–202.

    Article  CAS  PubMed  Google Scholar 

  23. Flandroy L, Poutahidis T, Berg G, Clarke G, Dao MC, Decaestecker E, et al. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ. 2018;627:1018–38.

    Article  CAS  PubMed  Google Scholar 

  24. Kim JE, Kim HS. Microbiome of the skin and gut in atopic dermatitis (AD): understanding the pathophysiology and finding Novel Management Strategies. J Clin Med. 2019;8(4):444.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53(5):685–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Cohen NA, Maharshak N. Novel indications for fecal microbial transplantation: update and review of the literature. Dig Dis Sci. 2017;62(5):1131–45.

    Article  PubMed  Google Scholar 

  27. Abrahamsson TR, Jakobsson T, Björkstén B, Oldaeus G, Jenmalm MC. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol. 2013;24(6):556–61.

    Article  PubMed  Google Scholar 

  28. Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate. World J Gastroenterol. 2016;22(32):7186–202.

    Article  PubMed  PubMed Central  Google Scholar 

  29. McFarland LV. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 2014;4(8):e005047.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Mennini M, Dahdah L, Artesani MC, Fiocchi A, Martelli A. Probiotics in Asthma and Allergy Prevention. Front Pediatr. 2017;5:165.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Prakoeswa CRS, Herwanto N, Prameswari R, Astari L, Sawitri S, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes. 2017;8(5):833–40.

    Article  CAS  PubMed  Google Scholar 

  32. Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB. The hygiene hypothesis: current perspectives and future therapies. Immunotargets Ther. 2015;4:143–57.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Tischer C, Kirjavainen P, Matterne U, Tempes J, Willeke K, Keil T, et al. Interplay between natural environment, human microbiota and immune system: a scoping review of interventions and future perspectives towards allergy prevention. Sci Total Environ. 2022;821:153422.

    Article  CAS  PubMed  Google Scholar 

  34. Nurminen N, Lin J, Grönroos M, Puhakka R, Kramna L, Vari HK, et al. Nature-derived microbiota exposure as a novel immunomodulatory approach. Future Microbiol. 2018;13:737–44.

    Article  CAS  PubMed  Google Scholar 

  35. Roslund MI, Puhakka R, Grönroos M, Nurminen N, Oikarinen S, Gazali AM, et al. Biodiversity intervention enhances immune regulation and health-associated commensal microbiota among daycare children. Sci Adv. 2020;6(42):eaba2578.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Roslund MI, Parajuli A, Hui N, Puhakka R, Grönroos M, Soininen L, et al. A placebo-controlled double-blinded test of the biodiversity hypothesis of immune-mediated diseases: environmental microbial diversity elicits changes in cytokines and increase in T regulatory cells in young children. Ecotoxicol Environ Saf. 2022;242:113900.

    Article  CAS  PubMed  Google Scholar 

  37. Soininen L, Roslund MI, Nurminen N, Puhakka R, Laitinen OH, Hyöty H, et al. Indoor green wall affects health-associated commensal skin microbiota and enhances immune regulation: a randomized trial among urban office workers. Sci Rep. 2022;12(1):6518.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Roslund MI, Puhakka R, Nurminen N, Oikarinen S, Siter N, Grönroos M, et al. Long-term biodiversity intervention shapes health-associated commensal microbiota among urban day-care children. Environ Int. 2021;157:106811.

    Article  PubMed  Google Scholar 

  39. González-Rodríguez MI, Nurminen N, Kummola L, Laitinen OH, Oikarinen S, Parajuli A, et al. Effect of inactivated nature-derived microbial composition on mouse immune system. Immun Inflamm Dis. 2022;10(3):e579.

    Article  PubMed  Google Scholar 

  40. Ottman N, Ruokolainen L, Suomalainen A, Sinkko H, Karisola P, Lehtimäki J, et al. Soil exposure modifies the gut microbiota and supports immune tolerance in a mouse model. J Allergy Clin Immunol. 2019;143(3):1198–1206e12.

    Article  CAS  PubMed  Google Scholar 

  41. Sanaei M, Mahdavi M, Setayesh N, Shahverdi AR, Sepehrizadeh Z, Yazdi MH. Comparison of Cytokine expression in human PBMCs stimulated with normal and heat-shocked Lactobacillus plantarum cell lysate. Probiotics Antimicrob Proteins. 2021;13(6):1539–45.

    Article  CAS  PubMed  Google Scholar 

  42. Zago M, Massimiliano L, Bonvini B, Penna G, Giraffa G, Rescigno M. Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from italian hard cheeses. PLoS ONE. 2021;16(1):e0245903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Cabeza-Cabrerizo M, Cardoso A, Minutti CM, Pereira da Costa M. Reis e Sousa C. Dendritic cells revisited. Annu Rev Immunol. 2021;39:131–66.

    Article  CAS  PubMed  Google Scholar 

  44. Perner C, Flayer CH, Zhu X, Aderhold PA, Dewan ZNA, Voisin T, et al. Substance P release by sensory neurons Triggers Dendritic Cell Migration and initiates the Type-2 Immune response to Allergens. Immunity. 2020;53(5):1063–1077e7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Yang Y, Tung JW, Ghosn EEB, Herzenberg LA, Herzenberg LA. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci USA. 2007;104(11):4542–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Choi YS, Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med. 2008;205(13):3053–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Prieto JMB, Felippe MJB. Development, phenotype, and function of non-conventional B cells. Comp Immunol Microbiol Infect Dis. 2017;54:38–44.

    Article  CAS  PubMed  Google Scholar 

  48. Colamatteo A, Carbone F, Bruzzaniti S, Galgani M, Fusco C, Maniscalco GT, et al. Molecular Mechanisms Controlling Foxp3 expression in Health and Autoimmunity: from epigenetic to post-translational regulation. Front Immunol. 2020;10:3136.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut RORγ + regulatory T cell homeostasis. Nature. 2020;577(7790):410–5.

    Article  CAS  PubMed  Google Scholar 

  50. Yang BH, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M, et al. Foxp3 + T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 2016;9(2):444–57.

    Article  CAS  PubMed  Google Scholar 

  51. Ohnmacht C. Tolerance to the intestinal microbiota mediated by ROR(γt) + cells. Trends Immunol. 2016;37(7):477–86.

    Article  CAS  PubMed  Google Scholar 

  52. Habtezion A, Nguyen LP, Hadeiba H, Butcher EC. Leukocyte trafficking to the small intestine and Colon. Gastroenterology. 2016;150(2):340–54.

    Article  CAS  PubMed  Google Scholar 

  53. Hänninen A, Toivonen R, Pöysti S, Belzer C, Plovier H, Ouwerkerk JP, et al. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut. 2018;67(8):1445–53.

    Article  PubMed  Google Scholar 

  54. Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 2016;532(7600):512–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Grönroos M, Parajuli A, Laitinen OH, Roslund MI, Vari HK, Hyöty H, et al. Short-term direct contact with soil and plant materials leads to an immediate increase in diversity of skin microbiota. Microbiologyopen. 2019;8(3):e00645.

    Article  PubMed  Google Scholar 

  56. DiPiazza AT, Hill JP, Graham BS, Ruckwardt TJ. OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional characterization of Murine Antigen-Presenting cells. Cytometry A. 2019;95(12):1226–30.

    Article  CAS  PubMed  Google Scholar 

Download references


The authors acknowledge the Tampere Facility of Flow Cytometry for their service.


This work was supported by the Academy of Finland (ISJ: grants: 25013080481 and 25013142041), The Competitive State Research Financing of the Expert Responsibility Area of Fimlab Laboratories (grant X51409 to ISJ), Nordlab Laboratories (grant: X3710-KT0011 for IJ) and Tampere Tuberculosis Foundation (ISJ). Business Finland (grants: 9204/31/2019 (AS), 7947/31/2017 (HH, OHL, NN). Finnish Cultural Foundation (MGR), Finnish Concordia Fund (TS) and Allergy Research Foundation (MGR, TS). None of the funding bodies participated in any way in the design of the study, the data collection, analysis or interpretation or writing of the manuscript.

Open access funding provided by Tampere University including Tampere University Hospital, Tampere University of Applied Sciences (TUNI).

Author information

Authors and Affiliations



LK, MGR, PM, IM, NN, TS, LH, OHL planned and performed the experiments, AS, HH and ISJ conceived the idea, received funding, planned the experiments, and oversaw the project. LK, MGR and NN analyzed the data. LK, MGR, AS, HH and ISJ wrote the MS. All authors reviewed the manuscript.

Corresponding author

Correspondence to Ilkka S. Junttila.

Ethics declarations

Competing interests

HH, OHL and AS are stakeholders and members of the board of Uute Scientific LtD which develops biodiversity-based interventions for the prevention of immune mediated diseases. In 2023, OHL receive 50% and IM 100% of their monthly salary from US. A.S., H.H. O.H.L., N.N. have been named as inventors in a patent application “immunomodulatory compositions” submitted by University of Helsinki (patent application number 20165932 at Finnish Patent and Registration Office). A.S. is named as an inventor in a patent application “Immunomodulatory gardening and landscaping material” submitted by University of Helsinki (patent application number 175196 at Finnish Patent and Registration Office). AS has received royalties from the patent application 20165932. All other authors don’t have any conflict/competing interest.

Ethics approval and consent to participate

This animal study and experiments were assessed and approved by the Tampere University Animal Facility Care and Use committee. Furthermore, all animal work was approved and performed under the Finnish Regional State Administrative Agency (AVI, Hämeenlinna, Finland) animal permit number ESAVI/971/2021. All experiments were performed in accordance to Directive 2010/63/EU in Europe and Tampere University Animal facility regulation.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kummola, L., González-Rodríguez, M., Marnila, P. et al. Comparison of the effect of autoclaved and non-autoclaved live soil exposure on the mouse immune system. BMC Immunol 24, 29 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: